11/7
07:02 am
qttb
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
11/7
06:59 am
qttb
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/5
06:59 am
qttb
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
Medium
Report
Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
10/24
07:16 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock.
Low
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Raymond James. They set a "strong-buy" rating and a $90.00 price target on the stock.
10/14
07:05 am
qttb
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
Medium
Report
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 [Yahoo! Finance]
10/14
06:59 am
qttb
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
Medium
Report
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
9/11
08:02 am
qttb
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
Low
Report
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $95.00 price target on the stock.
8/29
06:59 am
qttb
Q32 Bio to Participate in Upcoming September Investor Conferences
Medium
Report
Q32 Bio to Participate in Upcoming September Investor Conferences
8/29
03:55 am
qttb
Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 [Seeking Alpha]
Medium
Report
Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 [Seeking Alpha]